These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27099955)

  • 21. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
    JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
    Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
    Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Complement Factor C2/C3/CFB/CFH Polymorphisms and Age-Related Macular Degeneration: A Meta-Analysis.
    Lu F; Liu S; Hao Q; Liu L; Zhang J; Chen X; Hu W; Huang P
    Genet Test Mol Biomarkers; 2018 Sep; 22(9):526-540. PubMed ID: 30179527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study.
    Roshanipour N; Laleh MG; Bonyadi M; Bonyadi MHJ; Soheilian M; Javadzadeh A; Yaseri M
    BMC Ophthalmol; 2020 Aug; 20(1):323. PubMed ID: 32762675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetic variant rs4073 A→T of the Interleukin-8 promoter region is associated with the earlier onset of exudative age-related macular degeneration.
    Hautamäki A; Seitsonen S; Holopainen JM; Moilanen JA; Kivioja J; Onkamo P; Järvelä I; Immonen I
    Acta Ophthalmol; 2015 Dec; 93(8):726-33. PubMed ID: 26154559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene polymorphisms associated with an increased risk of exudative age-related macular degeneration in a Spanish population.
    Gili P; Lloreda Martín L; Martín-Rodrigo JC; Kim-Yeon N; Modamio-Gardeta L; Fernández-García JL; Rebolledo-Poves AB; Gómez-Blazquez E; Pazos-Rodriguez R; Pérez-Fernández E; Velasco M
    Eur J Ophthalmol; 2022 Jan; 32(1):651-657. PubMed ID: 33765843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
    Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
    Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a chinese population.
    Pei XT; Li XX; Bao YZ; Yu WZ; Yan Z; Qi HJ; Qian T; Xiao HX
    Curr Eye Res; 2009 Aug; 34(8):615-22. PubMed ID: 19899988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of risk alleles in patients with age-related macular degeneration.
    Nielsen MK; Subhi Y; Molbech CR; Grønskov K; Sørensen TL
    Dan Med J; 2020 Mar; 67(3):. PubMed ID: 32138827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration.
    Lechanteur YT; van de Camp PL; Smailhodzic D; van de Ven JP; Buitendijk GH; Klaver CC; Groenewoud JM; den Hollander AI; Hoyng CB; Klevering BJ
    JAMA Ophthalmol; 2015 May; 133(5):533-41. PubMed ID: 25695752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype associations in neovascular age-related macular degeneration.
    Hogg RE; McKay GJ; Hughes AE; Muldrew KA; Chakravarthy U
    Retina; 2012 Oct; 32(9):1950-8. PubMed ID: 22487577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).
    Hagstrom SA; Ying GS; Pauer GJ; Sturgill-Short GM; Huang J; Maguire MG; Martin DF;
    JAMA Ophthalmol; 2014 May; 132(5):521-7. PubMed ID: 24652518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
    Mullins RF; McGwin G; Searcey K; Clark ME; Kennedy EL; Curcio CA; Stone EM; Owsley C
    Ophthalmology; 2019 Apr; 126(4):591-600. PubMed ID: 30389424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.
    de Jong EK; Breukink MB; Schellevis RL; Bakker B; Mohr JK; Fauser S; Keunen JE; Hoyng CB; den Hollander AI; Boon CJ
    Ophthalmology; 2015 Mar; 122(3):562-70. PubMed ID: 25439433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population.
    Nakata I; Yamashiro K; Yamada R; Gotoh N; Nakanishi H; Hayashi H; Akagi-Kurashige Y; Tsujikawa A; Otani A; Saito M; Iida T; Oishi A; Matsuo K; Tajima K; Matsuda F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):794-8. PubMed ID: 22232432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of genetic variants rs641153 (
    Neto JM; Viturino MG; Ananina G; Bajano FF; Costa SMDS; Roque AB; Borges GF; Franchi R; Rim PH; Medina FM; Costa FF; Melo MB; de Vasconcellos JP
    Exp Biol Med (Maywood); 2021 Nov; 246(21):2290-2296. PubMed ID: 34233521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of scar in the comparison of age-related macular degeneration treatments trials.
    Daniel E; Toth CA; Grunwald JE; Jaffe GJ; Martin DF; Fine SL; Huang J; Ying GS; Hagstrom SA; Winter K; Maguire MG;
    Ophthalmology; 2014 Mar; 121(3):656-66. PubMed ID: 24314839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study.
    Farwick A; Dasch B; Weber BH; Pauleikhoff D; Stoll M; Hense HW
    Eye (Lond); 2009 Dec; 23(12):2238-44. PubMed ID: 19169232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation.
    Hayashi H; Yamashiro K; Gotoh N; Nakanishi H; Nakata I; Tsujikawa A; Otani A; Saito M; Iida T; Matsuo K; Tajima K; Yamada R; Yoshimura N
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5914-9. PubMed ID: 20574013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.